Gregory Collier

Gregory Collier was the founder of Gemini Biotechnology, founded in 2012, serving as Director from 2012 to 2022.
Dr. Collier is the founder of Prevatex Pty Ltd., founded in 2020, serving as Executive Chairman since 2020.
Dr. Collier currently serves as Non-Executive Chairman at Avecho Biotechnology Ltd. since 2019, with employment at the company starting in 2015.
Dr. Collier currently serves as Chairman at Tessara Therapeutics Pty Ltd. since 2019.
Former positions include Chief Executive Officer & Managing Director at ChemGenex Pharmaceuticals, Inc., Non-Executive Director at Photonz Corp.
Ltd., Non-Executive Director at Invion Ltd. in 2019, Director at VITALITY Devices Pty Ltd., Director at Barwon Biotechnology Pty Ltd., Director at Fusion Biosciences Pty Ltd., Principal at the University of Melbourne, Principal at Monash University, Principal at the University of Toronto, and Professor at Deakin University.
Education includes undergraduate studies at the University of Melbourne and a doctorate from Monash University.